Clinical Trials Browser

Phase 1/2 × Leukemia, Myeloid, Acute × troxacitabine × Clear all

NCT00104468 2008-01-17

Study of Troxatyl™ Administered by Continuous Infusion to Subjects With Refractory Acute Myelogenous Leukemia (AML)

Phase 1/2 Terminated

Other hematologic neoplasm

Leukemia, Myeloid, Acute